Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders.
substance abuse treatment
Advocate and Leader to End Opioid Misuse
Through the Opioid Task Force, Healing Network, and Pharmacy Examining Board, pharmacist alum John Weitekamp works to protect patients.
Four Stages to Improve Substance Misuse Therapy
Through a string of NIH grants, Assistant Professor Jay Ford advances critical research to improve access to medication-assisted therapy for opioid use disorder.
Breaking Down Barriers to Substance Abuse Treatment
School of Pharmacy researchers illuminate and address pharmacists’ barriers to providing naltrexone injections for substance abuse treatment.